Literature DB >> 2984345

Prognosis for Wilms' tumor patients with nonmetastatic disease at diagnosis--results of the second National Wilms' Tumor Study.

N Breslow, G Churchill, J B Beckwith, D J Fernbach, H B Otherson, M Tefft, G J D'Angio.   

Abstract

Multivariate statistical methods were used to study prognosis for 632 patients entered on the second National Wilms' Tumor Study who had nonmetastatic, unilateral disease at diagnosis. Separate analyses were conducted for each of four endpoints: abdominal recurrence, distant metastasis, relapse without regard to site, and death. The two most important predictors for metastasis and general relapse were an unfavorable (anaplastic or sarcomatous) histology and the presence of microscopically confirmed disease in the regional lymph nodes. Operative spillage of tumor increased the rates of abdominal recurrence and death, even after accounting for histology and lymph node effects. The presence of a tumor thrombus in the renal vein or IVC increased the risk of metastasis, and intrarenal vascular invasion was associated with general relapse after accounting for histology, lymph nodes, and spillage. However, these latter associations were weaker, and some uncertainty remains regarding the true prognostic import of such findings due to a high degree of collinearity among variables. By contrast to the results of a similar data analysis for the first National Wilms' Tumor Study, specimen weight had no bearing on outcome, and the effects of age at diagnosis were entirely explained by the association of age with other more critical factors.

Entities:  

Mesh:

Year:  1985        PMID: 2984345     DOI: 10.1200/JCO.1985.3.4.521

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  9 in total

1.  Lymph node involvement in Wilms tumor: results from National Wilms Tumor Studies 4 and 5.

Authors:  Kathleen Kieran; James R Anderson; Jeffrey S Dome; Peter F Ehrlich; Michael L Ritchey; Robert C Shamberger; Elizabeth J Perlman; Daniel M Green; Andrew M Davidoff
Journal:  J Pediatr Surg       Date:  2012-04       Impact factor: 2.545

2.  Surgery-related factors and local recurrence of Wilms tumor in National Wilms Tumor Study 4.

Authors:  R C Shamberger; K A Guthrie; M L Ritchey; G M Haase; J Takashima; J B Beckwith; G J D'Angio; D M Green; N E Breslow
Journal:  Ann Surg       Date:  1999-02       Impact factor: 12.969

3.  Secondary malignant neoplasms after Wilms tumor: an international collaborative study.

Authors:  Norman E Breslow; Jane M Lange; Debra L Friedman; Daniel M Green; Mike M Hawkins; Michael F G Murphy; Joseph P Neglia; Jørgen H Olsen; Susan M Peterson; Charles A Stiller; Leslie L Robison
Journal:  Int J Cancer       Date:  2010-08-01       Impact factor: 7.396

4.  Primary nephrectomy and intraoperative tumor spill: report from the Children's Oncology Group (COG) renal tumors committee.

Authors:  Kenneth W Gow; Douglas C Barnhart; Thomas E Hamilton; Jessica J Kandel; Mike K S Chen; Fernando A Ferrer; Mitchell R Price; Elizabeth A Mullen; James I Geller; Eric J Gratias; Nancy Rosen; Geetika Khanna; Arlene Naranjo; Michael L Ritchey; Paul E Grundy; Jeffrey S Dome; Peter F Ehrlich
Journal:  J Pediatr Surg       Date:  2013-01       Impact factor: 2.545

5.  Recent experience with Wilms' tumor: 1978-1991.

Authors:  R C Shamberger; R M Macklis; S E Sallan
Journal:  Ann Surg Oncol       Date:  1994-01       Impact factor: 5.344

6.  Ureteral extension in Wilms' tumor: a report from the National Wilms' Tumor Study Group (NWTSG).

Authors:  Michael Ritchey; Shane Daley; Robert C Shamberger; Peter Ehrlich; Thomas Hamilton; Gerald Haase; Robert Sawin
Journal:  J Pediatr Surg       Date:  2008-09       Impact factor: 2.545

7.  Outcome of patients with Stage II/favorable histology Wilms tumor with and without local tumor spill: a report from the National Wilms Tumor Study Group.

Authors:  Daniel M Green; Norman E Breslow; Giulio J D'Angio; Marcio H Malogolowkin; Michael L Ritchey; Audrey E Evans; J Bruce Beckwith; Elizabeth J Perlman; Robert C Shamberger; Susan Peterson; Paul E Grundy; Jeffrey S Dome; Patrick R M Thomas; John A Kalapurakal
Journal:  Pediatr Blood Cancer       Date:  2013-08-23       Impact factor: 3.167

8.  The predictive value of immunohistochemical markers in untreated Wilms' tumour: are they useful?

Authors:  Mazen A Ghanem; Theo H van der Kwast; W M Molenaar; Manal A Safan; Rien J Nijman; Gert Jan van Steenbrugge
Journal:  World J Urol       Date:  2011-05-19       Impact factor: 4.226

Review 9.  Recent advances in the management of Wilms' tumor.

Authors:  Roberto I Lopes; Armando Lorenzo
Journal:  F1000Res       Date:  2017-05-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.